An Observational Study to Assess the Long-Term Follow-Up of Subjects Who Had Participated in SKY0402 Breast Augmentation Studies.
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 11 May 2012 Primary endpoint identified as (implantation rate) as reported by ClinicalTrials.gov.
- 11 May 2012 Location (USA) added as reported by ClinicalTrials.gov.
- 26 Sep 2011 Results presented at the 2011 Annual Meeting of the American Society of Plastic Surgeons, according to a Pacira Pharmaceuticals media release.